Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Prepaid Assets (2016 - 2025)

IGC Pharma has reported Prepaid Assets over the past 15 years, most recently at $130000.0 for Q3 2025.

  • Quarterly Prepaid Assets fell 70.05% to $130000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $130000.0 through Sep 2025, down 70.05% year-over-year, with the annual reading at $342000.0 for FY2025, 64.42% up from the prior year.
  • Prepaid Assets was $130000.0 for Q3 2025 at IGC Pharma, down from $212000.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $1.7 million in Q3 2021 and troughed at $12000.0 in Q2 2021.
  • The 5-year median for Prepaid Assets is $216000.0 (2023), against an average of $358277.8.
  • The largest YoY upside for Prepaid Assets was 1225.0% in 2022 against a maximum downside of 74.05% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $1.7 million in 2021, then plummeted by 93.17% to $114000.0 in 2022, then grew by 8.77% to $124000.0 in 2023, then skyrocketed by 145.16% to $304000.0 in 2024, then crashed by 57.24% to $130000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Prepaid Assets are $130000.0 (Q3 2025), $212000.0 (Q2 2025), and $342000.0 (Q1 2025).